Navigation Links
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
Date:9/25/2010

and feeling hot. Most adverse reactions began soon after dosing, and generally resolved within approximately 15 minutes, except for headache, which resolved in most patients within 30 minutes.

In postmarketing experience, abdominal pain in association with nausea, vomiting, or myalgias, and diarrhea, fecal incontinence, musculoskeletal pain, and tremor have occurred.

Complete prescribing information for Lexiscan is available at www.astellas.us/docs/lexiscan.pdf.  For more information on Lexiscan, please visit www.lexiscan.com.

About Astellas

The Astellas culture and brand is committed to building community, helping others, encouraging

integrity and inspiring people to make a difference, today, tomorrow and every day. Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the United States, Astellas markets products in the areas of Anti-Infectives, Cardiology, Dermatology, Neuroscience, Transplant, and Urology. For more information about Astellas Pharma US, Inc., please visit our website at www.astellas.us or follow us on Twitter at www.Twitter.com/AstellasUS.

References

  1. Prenner BM, McNutt BE. A Study of the Safety and Tolerance of Regadenoson in Subjects with Asthma or Chronic Obstructive Pulmonary Disease. Presented at: 15th Annual Scientific Sessions of the American Society of Nuclear Cardiology; September 2010; Philadelph
    '/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
4. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
7. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
8. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
9. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
10. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
11. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - The Canadian Epilepsy ... new comic series designed to educate children about the most ... The Medikidz Explain Epilepsy comic series tells a ... is navigating middle school while living with epilepsy. ... Canadians, there is still so much misinformation and lack of ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans ... OxyContin is a serious public health and safety issue in ... from a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication ... progress with this very serious health situation facing our country," ...
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS International, ... Manufacturing Intelligence , today announces Infusion Chicago, ... event will be held Oct. 9-10, 2014, at ... designed to showcase the necessity for implementing a ... and Manufacturing Intelligence to gain insight into production ...
Breaking Medicine Technology:Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
... ... , LONDON, Dec. 14 A new solution developed by IBM ... Malaria Partnership, is helping to save lives using everyday technology to ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091214/NY25146-a ) , (Photo: ...
... , GENEVA, Switzerland, December 14 ... Meeting was held,in Bermuda on 7th December. In excess of ... and overwhelmingly approved all the resolutions,put forward. , ... Shortt of Galmoy,as the new Director of Corporate Communications. In ...
Cached Medicine Technology:Saving Lives with SMS for Life 2Saving Lives with SMS for Life 3Saving Lives with SMS for Life 4Saving Lives with SMS for Life 5Calcitech Holds Annual General Meeting 2
(Date:8/22/2014)... disabilities and multiple chronic conditions are screened for breast ... no chronic conditions, a new study has found. , ... moderate disabilities or women with only one chronic condition, ... the Li Ka Shing Knowledge Institute of St. Michael,s ... have other measures of social vulnerability, such as low ...
(Date:8/22/2014)... August 22, 2014 Key West Health ... experts revealed their much anticipated study results of the ... today and released an accompanying infographic on their website. ... can have a major impact on the skin and ... and more. , When asked how they determined the ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Until now, those ... standard crutches or walkers to keep mobile. Thanks to an ... made much more effective. , He developed a prototype for ... an injured leg or foot but provide comfort and reduce ... to different heights, it is also convenient and easy to ...
(Date:8/22/2014)... Chest pain, breathing difficulties, fainting. Each year approx. 265,000 ... of serious illness. New research from Aarhus University and ... as many as every fourth patient are ... severe symptoms that led to the acute hospitalisation., "Naturally, ... examinations at the hospital disprove that there is a ...
(Date:8/22/2014)... lactose intolerance. However, these are two entirely different mechanisms ... do not digest lactose properly because they lack an ... potentially much more dangerous cow milk allergy, however, the ... IgE antibodies. , According to statistics, about two to ... genuine milk allergy. Less adults are diagnosed with the ...
Breaking Medicine News(10 mins):Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Many patients are discharged without a diagnosis 2Health News:Scientists uncover why major cow milk allergen is actually allergenic 2
... will now enable Indians who have acquired medical degrees from ... will be conducted by the National Board of Examinations (An ... The purpose of the registration is only to qualify for ... Medical Council and shall not confer any other right whatsoever ...
... to suffer from the negative effects of coffee that has ... the coffee. Caffeinated coffee has been found to boost blood ... risk of heart disease. However, a new study by Dutch ... Nutrition claims that caffeine might not be the only ingredient ...
... new study published by New England Journal of Medicine ... of peripheral arterial disease(PAD) may benefit from walking a ... ,Kerry J. Stewart, Johns Hopkins University, Director of Clinical ... pain during exercise, so they stop, which makes them ...
... recent health survey across England showed that many do ... cancer and other serious diseases. The survey included nearly// ... trends were revealed by the study. ,The survey ... eating and household income. Almost 40% of women in ...
... environment and self to lead healthy, disease free lives. ... habit of hand washing could help us reduce the risk of ... get our hands dirty, apart from heavy house work and gardening, ... not bother to wash our hands even before a meal. Recent ...
... Breast cancer has been associated to many risk factors ... alcohol consumption. Several earlier studies have linked alcohol to ... also because smoking often accompanies drinking, researchers have not ... ,Now, researchers from Cancer Research, UK, who included ...
Cached Medicine News:Health News:Caffeine is not the only culprit in coffee! 2
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Cfix cable fixation system is a flexible ... need for crimping and address the surgeon's ... mechanism provides the surgeon with the ability ... required prior to final cutting without the ...
... System is a unique and versatile posterior ... fusion constructs, as a translational implant in ... anchoring element for bone or metallic implants, ... of implant configurations. Songer Cables offer advantages ...
Specially designed combination of demineralized bone fibers and demineralized bone cubes that are both osteoinductive and osteoconductive. Packs well into bone defects. Eliminates the need to mix can...
Medicine Products: